Check out👀our latest analysis in JAHA Clinical Significance of Exercise Pulmonary Hypertension With a Negative Diastolic Stress Test for Suspected Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association (ahajournals.org) 1/🧵

🫀 VT or SVT with aberrancy? EKG signs suggesting VT: - Absence of typical RBBB/LBBB morphology - Extreme axis deviation (QRS + in aVR, - in I/aVF) - Broad QRS >160 ms - AV dissociation - Capture beats - Fusion beats #CardioTwitter #MedTwitter

🫀The Velocity Time Integral (VTI) is a measure used in echo to estimate the distance a column of blood travels during one cardiac cycle i.e. per heartbeat. VTI is often used in calculating stroke volume and CO. #CardioTwitter

🧵 Tweetorial: Visualizing Lymphatic Flow in Heart Failure Patients Using Indocyanine Green Fluorescence Lymphography pubmed.ncbi.nlm.nih.gov/39170955/ JACC Journals Led by Barbara Ponikowska @Wroclaw_Medical_Univ

Check out our editorial on the FAIR-HFpEF trial in EHJ!! Thanks to my incredible mentor Robert Mentz, MD for the opportunity to work on this! European Society of Cardiology Journals Duke Clinical Research Institute Duke Cardiology Fellows

🚨 Just published 🚨 Our systematic review explores the role of plasma exchange and combined therapies in managing dengue-associated acute liver failure 🦟 🦟🦟 ☠️🪦Rare but deadly: Acute Liver Failure (ALF) in severe dengue infection can lead to multi-organ failure, often due

New 2024 #ESCGuidelines on #Afib Clear pathways for management of 💡first-diagnosed AF 💡paroxysmal AF 💡persistent AF 💡permanent AF #ESCCongress European Society of Cardiology

🔥 fresh SoA review 🔥 JACC Journals To supplement discussion of #MRA European Society of Cardiology News European Society of Cardiology We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.

RESHAPE-HF2 out JACC Journals & NEJM - joining the ranks of the pivotal COAPT & MITRAFR, and possibly acting as a tie-breaker. Check out our editorial proposing an LV volume-based framework to reconcile the 3 trials #miltonpacker Raj Makkar Paul Grayburn jacc.org/doi/10.1016/j.…

🔥🔥🔥 An essential resource! Outstanding review on steroidal versus nonsteroidal MRA in HF. All trials, mechanisms, profiles. Andrew J Sauer MD Harriette Van Spall, MD MPH Andrew P. Ambrosy, MD #JACCHF JACC Journals jacc.org/doi/10.1016/j.…

Severe #MitralRegurgitation cut offs in a pinch: 1,2,3 is too easy. So remember 4,5,6,7: ✅ EROA 0.4cm2 ✅Regurgitant Fraction 50% ✅Regurgitant volume 60mL ✅ Vena contracts width 0.7cm

🧵1/🚨Major update in HF! The latest HFSA scientific statement highlights the growing role of device-based therapies in tackling unmet needs in chronic HF & provides a framework for integrating them into current clinical workflows. onlinejcf.com/article/S1071-…

🧵1/ Heart failure (HF) monitoring is crucial for preventing hospitalizations. Current tools aren't sensitive enough, leading to missed events and unnecessary admissions. Introducing SCALE-HF 1, a novel study evaluating a better way to monitor HF remotely! onlinejcf.com/article/S1071-…

1/ Published today, the Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery 📷: Stepwise Approach to Perioperative Cardiac Assessment.

Stay tuned tomorrow, will have Jae K. Oh presenting to us Houston Methodist about constrictive pericarditis, timely after the publication of an international statement by Allan L. Klein . Looking forward to hosting him. WilliamZoghbi. Link to watch live vimeo.com/event/4485244

Mavacamten was associated with reductions in biomarkers of cardiac wall stress and injury, with no sustained reductions in LVEF observed in patients with HFpEF and LVEF of 60% or greater. ja.ma/3zCCfsP

Check out our review on atrial mechanics and interventions in Journal of Cardiac Failure HFxIC collab issue "Atrial interventions could ⬇️affect atrial function ➡️symptoms/HF" We discuss 1⃣ atrial mechanics 2⃣ atrial CM 3⃣ impact of atrial interventions 🧵1/6

Had an amazing time at #CHEST2024 Honored to present my research! ✔️Oral presentation: Lung Cancer Outcomes ✔️5 first author poster presentations ✔️Invaluable networking & learning opportunities Boston, you will be missed! ⭐️ Next stop: ASH’24. See you there!